- Home
- TLSA vs BNTC Comparison
TLSA vs BNTC Comparison
Compare TLSA & BNTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLSA
- BNTC
- Stock Information
- Founded
- TLSA 2013
- BNTC 1995
- Country
- TLSA United Kingdom
- BNTC United States
- Employees
- TLSA N/A
- BNTC N/A
- Industry
- TLSA Biotechnology: Pharmaceutical Preparations
- BNTC Biotechnology: Pharmaceutical Preparations
- Sector
- TLSA Health Care
- BNTC Health Care
- Exchange
- TLSA Nasdaq
- BNTC Nasdaq
- Market Cap
- TLSA 175.3M
- BNTC 366.6M
- IPO Year
- TLSA 2000
- BNTC N/A
- Fundamental
- Price
- TLSA $1.57
- BNTC $12.74
- Analyst Decision
- TLSA
- BNTC Strong Buy
- Analyst Count
- TLSA 0
- BNTC 6
- Target Price
- TLSA N/A
- BNTC $23.83
- AVG Volume (30 Days)
- TLSA 260.0K
- BNTC 219.6K
- Earning Date
- TLSA 07-11-2025
- BNTC 05-14-2025
- Dividend Yield
- TLSA N/A
- BNTC N/A
- EPS Growth
- TLSA N/A
- BNTC N/A
- EPS
- TLSA N/A
- BNTC N/A
- Revenue
- TLSA N/A
- BNTC N/A
- Revenue This Year
- TLSA N/A
- BNTC N/A
- Revenue Next Year
- TLSA N/A
- BNTC N/A
- P/E Ratio
- TLSA N/A
- BNTC N/A
- Revenue Growth
- TLSA N/A
- BNTC N/A
- 52 Week Low
- TLSA $0.63
- BNTC $7.05
- 52 Week High
- TLSA $1.91
- BNTC $17.15
- Technical
- Relative Strength Index (RSI)
- TLSA 52.76
- BNTC 40.67
- Support Level
- TLSA $1.53
- BNTC $10.91
- Resistance Level
- TLSA $1.81
- BNTC $12.74
- Average True Range (ATR)
- TLSA 0.11
- BNTC 1.39
- MACD
- TLSA -0.01
- BNTC -0.41
- Stochastic Oscillator
- TLSA 45.45
- BNTC 29.56
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in the developing transformative therapies for neurodegenerative and lung diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.
About BNTC Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.